<DOC>
	<DOCNO>NCT01213615</DOCNO>
	<brief_summary>Since first implant September 1982 , Medtronic Hancock® II provide 20 year excellent hemodynamic performance durability . Design improvement past generation include : low profile , flexible stent , Supra-X™ supra-annular placement , T6 anti-calcification tissue treatment , modify fixation process , CINCH® advance implant system ULTRA™ minimize sew ring . Valve size critical consideration obtain optimal hemodynamic performance . This particular true small aortic root . A critical issue size prosthesis relation patient 's annulus . The objective clinical study evaluate , six twelve month , hemodynamic performance HancockÒ Ultra™ bioprosthesis aortic position , analyze incidence patient prosthesis mismatch , correlation gradient , ascertain frequency large valve size use vs. patient 's debrided annulus diameter .</brief_summary>
	<brief_title>Hancock II Ultra Porcine Bioprosthesis Hemodynamic Study</brief_title>
	<detailed_description />
	<mesh_term>Heart Valve Diseases</mesh_term>
	<criteria>Patients require aortic valve replacement without coronary artery bypass graft surgical treatment atrial fibrillation mitral valve repair . Patients able provide inform consent . Concomitant procedure coronary artery bypass grafting , surgical treatment atrial fibrillation mitral valve repair . Patients indicate receive mechanical prosthesis . Patients replacement exist valve prosthesis . Patients refuse able provide inform consent . Patients require emergency surgery . Patients unable participate followup</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>